Genetic Technologies Ltd
ASX:GTG

Watchlist Manager
Genetic Technologies Ltd Logo
Genetic Technologies Ltd
ASX:GTG
Watchlist
Price: 0.039 AUD
Market Cap: 52.1m AUD
Section:
 

Relative Value

GTG doesn't have a meaningful market cap.

The Relative Value of one GTG stock under the Base Case scenario is 0.027 AUD. Compared to the current market price of 0.039 AUD, Genetic Technologies Ltd is Overvalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GTG Relative Value
Base Case
0.027 AUD
Overvaluation 31%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

14.1
P/S
P/S
Price to Sales
14.1
vs History
69
vs Industry
87
Median 3Y
15
Median 5Y
43
Industry
4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-10
Median 5Y
-36.6
Industry
32
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-16.8
Median 5Y
-41.6
Industry
19.8
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-16
Median 5Y
-39.2
Industry
27.6
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
35
Median 3Y
28.5
Median 5Y
29.2
Industry
2.8
More Details
13.9
EV/S
EV/S
Enterprise Value to Sales
13.9
vs History
69
vs Industry
89
Median 3Y
14.6
Median 5Y
42.5
Industry
4
More Details
30.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
30.3
vs History
44
vs Industry
85
Median 3Y
30.3
Median 5Y
30.3
Industry
9
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-12.7
Median 5Y
-36.8
Industry
19.8
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-12.7
Median 5Y
-36.8
Industry
24.5
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-16.3
Median 5Y
-41
Industry
20.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-16.2
Median 5Y
-40.7
Industry
27.3
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
53
Median 3Y
38.4
Median 5Y
55.2
Industry
2.3
More Details

Multiples Across Competitors

GTG Competitors Multiples
Genetic Technologies Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Genetic Technologies Ltd
ASX:GTG
52.1m AUD 14.1 -5.4 -7.4 -7.4
US
PerkinElmer Inc
LSE:0KHE
1.1T USD 376.3 4 457.5 1 370.2 2 893
US
Thermo Fisher Scientific Inc
NYSE:TMO
215.1B USD 4.9 32.7 23.4 30.2
US
Danaher Corp
NYSE:DHR
159.4B USD 6.6 45.5 24.4 36.9
CH
Lonza Group AG
SIX:LONN
35.6B CHF 5 48.5 37.1 37.1
US
Agilent Technologies Inc
NYSE:A
39.3B USD 5.7 30.2 23.3 27.8
US
IQVIA Holdings Inc
NYSE:IQV
38.2B USD 2.4 29.8 14.5 21.7
CN
WuXi AppTec Co Ltd
SSE:603259
259.1B CNY 5.8 17.3 19.7 19.7
KR
Samsung Biologics Co Ltd
KRX:207940
45.1T KRW 8.2 28.3 16.5 21.9
US
Mettler-Toledo International Inc
NYSE:MTD
28.4B USD 7.2 34 24.5 27.2
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.7B EUR 6.7 74.5 26.5 43.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Genetic Technologies Ltd
ASX:GTG
Average EV/EBITDA: 158
Negative Multiple: -7.4 		N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 370.2
5%
274
US
Thermo Fisher Scientific Inc
NYSE:TMO
23.4
5%
4.7
US
Danaher Corp
NYSE:DHR
24.4
5%
4.9
CH
Lonza Group AG
SIX:LONN
37.1
18%
2.1
US
Agilent Technologies Inc
NYSE:A
23.3
13%
1.8
US
IQVIA Holdings Inc
NYSE:IQV
14.5
8%
1.8
CN
WuXi AppTec Co Ltd
SSE:603259
19.7
30%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
16.5
21%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
24.5
4%
6.1
FR
Sartorius Stedim Biotech SA
PAR:DIM
26.5
20%
1.3

See Also

Summary
GTG intrinsic value, competitors valuation, and company profile.
DCF Valuation
GTG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GTG stock valuation using valuation multiples.
Wall Street Estimates
GTG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GTG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.